Concepedia

Kenn Ka-Hang Chik

KK

1

Publications

71

Citations

1

H-Index

2020

Active since

Affiliations

Hainan Medical University(Current)

Kenn Ka-Hang Chik is an author at Hainan Medical University specializing in pharmacotherapy, drug discovery, and drug development.

Top concepts

Publications per year

2020–2020

1

Publications

1

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Shuofeng Yuan, Jasper Fuk‐Woo Chan, Kenn Ka-Hang Chik et al. · Pharmacological Research · 2020 · 71 citations · Full text

, , +8

Rows per page

1–1 of 1